Becton Dickinson Cost of Goods Sold 2010-2024 | BDX
Becton Dickinson annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Becton Dickinson cost of goods sold for the quarter ending June 30, 2024 was $2.683B, a 3.42% decline year-over-year.
- Becton Dickinson cost of goods sold for the twelve months ending June 30, 2024 was $11.488B, a 9.4% increase year-over-year.
- Becton Dickinson annual cost of goods sold for 2023 was $11.202B, a 7.78% increase from 2022.
- Becton Dickinson annual cost of goods sold for 2022 was $10.393B, a 1.02% decline from 2021.
- Becton Dickinson annual cost of goods sold for 2021 was $10.5B, a 13.2% increase from 2020.
Becton Dickinson Annual Cost of Goods Sold
(Millions of US $) |
| 2023 |
$11,202 |
| 2022 |
$10,393 |
| 2021 |
$10,500 |
| 2020 |
$9,276 |
| 2019 |
$9,002 |
| 2018 |
$8,714 |
| 2017 |
$6,128 |
| 2016 |
$6,492 |
| 2015 |
$5,587 |
| 2014 |
$4,145 |
| 2013 |
$3,883 |
| 2012 |
$3,755 |
| 2011 |
$3,625 |
| 2010 |
$3,428 |
| 2009 |
$3,312 |
Becton Dickinson Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-06-30 |
$2,683 |
| 2024-03-31 |
$2,741 |
| 2023-12-31 |
$2,679 |
| 2023-09-30 |
$3,385 |
| 2023-06-30 |
$2,778 |
| 2023-03-31 |
$2,586 |
| 2022-12-31 |
$2,453 |
| 2022-09-30 |
$2,684 |
| 2022-06-30 |
$2,574 |
| 2022-03-31 |
$2,637 |
| 2021-12-31 |
$2,498 |
| 2021-09-30 |
$2,607 |
| 2021-06-30 |
$2,649 |
| 2021-03-31 |
$2,661 |
| 2020-12-31 |
$2,583 |
| 2020-09-30 |
$2,314 |
| 2020-06-30 |
$2,195 |
| 2020-03-31 |
$2,520 |
| 2019-12-31 |
$2,247 |
| 2019-09-30 |
$2,318 |
| 2019-06-30 |
$2,276 |
| 2019-03-31 |
$2,221 |
| 2018-12-31 |
$2,187 |
| 2018-09-30 |
$2,309 |
| 2018-06-30 |
$2,262 |
| 2018-03-31 |
$2,616 |
| 2017-12-31 |
$1,527 |
| 2017-09-30 |
$1,589 |
| 2017-06-30 |
$1,532 |
| 2017-03-31 |
$1,537 |
| 2016-12-31 |
$1,470 |
| 2016-09-30 |
$1,679 |
| 2016-06-30 |
$1,651 |
| 2016-03-31 |
$1,584 |
| 2015-12-31 |
$1,578 |
| 2015-09-30 |
$1,630 |
| 2015-06-30 |
$1,946 |
| 2015-03-31 |
$1,005 |
| 2014-12-31 |
$1,006 |
| 2014-09-30 |
$1,100 |
| 2014-06-30 |
$1,046 |
| 2014-03-31 |
$1,019 |
| 2013-12-31 |
$980 |
| 2013-09-30 |
$1,014 |
| 2013-06-30 |
$993 |
| 2013-03-31 |
$982 |
| 2012-12-31 |
$894 |
| 2012-09-30 |
$966 |
| 2012-06-30 |
$947 |
| 2012-03-31 |
$941 |
| 2011-12-31 |
$900 |
| 2011-09-30 |
$916 |
| 2011-06-30 |
$923 |
| 2011-03-31 |
$921 |
| 2010-12-31 |
$865 |
| 2010-09-30 |
$786 |
| 2010-06-30 |
$883 |
| 2010-03-31 |
$864 |
| 2009-12-31 |
$894 |
| 2009-09-30 |
$826 |
| 2009-06-30 |
$860 |
| 2009-03-31 |
$829 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$66.939B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
